BioVaxys Technology Corp. announced a delay in filing its audited annual financial statements for the year ended October 31, 2025, and interim financial statements for the three months ended January 31, 2026. The delay triggered a management cease trade order (MCTO) by the British Columbia Securities Commission, restricting trading by the CEO and CFO until filings are complete. The company expects to file all required documents by May 31, 2026, as its auditor requires more time to complete the audit. Despite the MCTO, the public can still trade BioVaxys shares freely, but insider trading and certain securities transactions are restricted until compliance is met.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
Gnosis (GNO) surged 13% in 24 hours, closing in on overtaking BONK by market capitalization to reach the 100th largest token spot. GNO's market cap stands at $303.88 million versus BONK's $330.07 million, requiring a price rise to about $125.48 for t...
Broadridge's Tokenization Pulse Survey shows 84% of firms view tokenization as strategically important, with 68% expecting it to reshape markets within 3-5 years. Most firms plan to integrate tokenization into existing infrastructure rather than buil...
Standard Chartered has partnered with Broadcom to modernize its global banking infrastructure by adopting a secure, resilient private cloud using VMware Cloud Foundation. This upgrade supports critical banking services across 54 markets with enhanced...
